Alto Neuroscience, Inc. (ANRO)
NYSE:ANRO
US Market
Holding ANRO?
Track your performance easily

Alto Neuroscience, Inc. (ANRO) Financial Statements

95 Followers

Alto Neuroscience, Inc. Financial Overview

Alto Neuroscience, Inc.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Alto Neuroscience, Inc. is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Sep 23Dec 22
Income Statement-
Total Revenue----
Gross Profit----
EBIT$ -16.03M---
EBITDA$ -15.86M---
Net Income Common Stockholders$ -16.03M$ -11.22M--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 193.12M$ 82.55M$ 51.29M$ 48.34M
Total Assets$ 197.36M$ 86.63M$ 53.24M$ 50.85M
Total Debt$ 10.06M$ 9.86M$ 9.76M$ 9.59M
Net Debt$ -183.06M$ -72.69M$ -41.53M$ -38.76M
Total Liabilities$ 17.58M$ 16.82M$ 17.25M$ 17.02M
Stockholders Equity$ 179.78M$ 69.81M$ 35.98M$ 33.83M
Cash Flow-
Free Cash Flow$ -12.03M$ -11.88M--
Operating Cash Flow$ -11.69M$ -11.52M--
Investing Cash Flow$ -340.00K$ -352.00K--
Financing Cash Flow$ -234.00K$ 43.13M--
Currency in USD

Alto Neuroscience, Inc. Earnings and Revenue History

Alto Neuroscience, Inc. Debt to Assets

Alto Neuroscience, Inc. Cash Flow

Alto Neuroscience, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis